Literature DB >> 23516308

Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis.

Franco Franchignoni1, Gabriele Mora, Andrea Giordano, Paolo Volanti, Adriano Chiò.   

Abstract

OBJECTIVE: To examine dimensionality, reliability and validity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R) using traditional classical test theory methods and Rasch analysis in order to provide a rationale for possible improvement of its metric quality.
METHODS: Methodological research on ALSFRS-R collected in a consecutive sample of 485 patients with amyotrophic lateral sclerosis (ALS) attending three tertiary ALS centres.
RESULTS: The ALSFRS-R items showed good internal consistency but dimensionality analysis argues against the use of ALSFRS-R as a single score because the scale lacks unidimensionality. Parallel analysis and exploratory factor analysis revealed three factors representing the following domains: (1) bulbar function; (2) fine and gross motor function; and (3) respiratory function. Rasch analysis showed that all items in each domain fitted the respective constructs to measure, except for item No 9 'climbing stairs' and item No 12 'respiratory insufficiency'. Rating categories did not comply with the criteria for category functioning. Collapsing the scale's 5 level ratings into 3 levels improved its metric quality.
CONCLUSIONS: The ALSFRS-R fails to satisfy rigorous measurement standards and should be, at least in part, revised. At present, ALSFRS-R should be considered as a profile of mean scores from three different domains (bulbar, motor and respiratory functions) more than a global total score. Further studies on ALSFRS-R using modern psychometric methods are warranted to confirm our findings and refine the metric quality of this scale, through a step by step process.

Entities:  

Keywords:  ALS

Mesh:

Year:  2013        PMID: 23516308     DOI: 10.1136/jnnp-2012-304701

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  41 in total

1.  Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.

Authors:  Jessica Mandrioli; Sara Angela Malerba; Ettore Beghi; Nicola Fini; Antonio Fasano; Elisabetta Zucchi; Silvia De Pasqua; Carlo Guidi; Emilio Terlizzi; Elisabetta Sette; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Lucia Zinno; Yasmin Handouk; Romana Rizzi; Annamaria Borghi; Rita Rinaldi; Doriana Medici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Marina Aiello; Salvatore Ferro; Marco Vinceti
Journal:  J Neurol       Date:  2018-02-05       Impact factor: 4.849

Review 2.  Prognostic factors for the course of functional status of patients with ALS: a systematic review.

Authors:  Huub Creemers; Hepke Grupstra; Frans Nollet; Leonard H van den Berg; Anita Beelen
Journal:  J Neurol       Date:  2014-11-11       Impact factor: 4.849

Review 3.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

4.  Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.

Authors:  Ming Tang; Chao Gao; Stephen A Goutman; Alexandr Kalinin; Bhramar Mukherjee; Yuanfang Guan; Ivo D Dinov
Journal:  Neuroinformatics       Date:  2019-07

5.  Strictly monitored exercise programs reduce motor deterioration in ALS: preliminary results of a randomized controlled trial.

Authors:  Christian Lunetta; Andrea Lizio; Valeria A Sansone; Nadia Maria Cellotto; Eleonora Maestri; Massimo Bettinelli; Valentina Gatti; Mario Giovanni Melazzini; Giovanni Meola; Massimo Corbo
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

Review 6.  Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Authors:  Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

7.  Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensor.

Authors:  Bjorn Oskarsson; Nanette C Joyce; Evan De Bie; Alina Nicorici; Ruzena Bajcsy; Gregorij Kurillo; Jay J Han
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

8.  Commonalities and challenges in the development of clinical trial measures in neurology.

Authors:  Jesse M Cedarbaum; Diane Stephenson; Richard Rudick; Maria C Carrillo; Glenn Stebbins; Douglas Kerr; Jill Heemskerk; Wendy R Galpern; Petra Kaufmann; David Cella; Maria Isaac; Marc K Walton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

9.  Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial.

Authors:  Mona Ahmadi; Elmira Agah; Shahriar Nafissi; Mahmoud Reza Jaafari; Mohammad Hossein Harirchian; Payam Sarraf; Sara Faghihi-Kashani; Seyed Jalal Hosseini; Abdolreza Ghoreishi; Vajiheh Aghamollaii; Mostafa Hosseini; Abbas Tafakhori
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

10.  Multidimensional latent trait linear mixed model: an application in clinical studies with multivariate longitudinal outcomes.

Authors:  Jue Wang; Sheng Luo
Journal:  Stat Med       Date:  2017-06-01       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.